Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices
Open Access
- 23 January 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 7 (2)
Abstract
Background: The number of implanted ventricular assist devices ( VAD s) has increased significantly recently. Bleeding, the most frequent complication, cannot be solely attributed to anticoagulation therapy. Acquired von Willebrand syndrome ( AVWS ) caused by increased shear stress is frequent in VAD patients and can increase the bleeding risk. The HeartMate III ( HM III ) is a novel left VAD featuring potential improvements over the HeartMate II . Methods and Results: In this study, we investigated the prevalence and onset of AVWS in 198 VAD patients. To our knowledge, this is the largest cohort of VAD patients whose longitudinal data on AVWS have been collected. We also analyzed whether AVWS is less severe in HM III patients than in HeartMate II patients. Because platelet dysfunction can raise the bleeding risk, we investigated platelet function in a subset of patients. In total, 198 VAD patients and 60 patients with heart transplants as controls were included in this study. The ratio of von Willebrand factor collagen binding capacity to von Willebrand factor:antigen, multimer analyses, and platelet function (especially secretion of α‐ and δ‐granules) were investigated. All 198 VAD patients developed AVWS . As soon as the VAD was explanted, the AVWS disappeared within hours. AVWS was less severe in the HM III patients than in the HeartMate II patients. The HM III patients had fewer bleeding symptoms. In addition, VAD patients exhibited a platelet α‐ and δ‐granule secretion defect. Conclusions: AVWS develops in VAD patients and may increase the bleeding risk. The HM III device causes less severe AVWS . Platelet secretion defects should be investigated in VAD patients because they also raise the bleeding risk. Clinical Trial Registration: https://www.drks.de/drks_web . Unique identifier: DRKS 00000649.Keywords
This publication has 40 references indexed in Scilit:
- VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESISMediterranean Journal of Hematology and Infectious Diseases, 2013
- Diagnosis and treatment of acquired von Willebrand syndromeThrombosis Research, 2012
- Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heartThrombosis and Haemostasis, 2010
- Haemolysis in patients with ventricular assist devices: major differences between systems☆European Journal of Cardio-Thoracic Surgery, 2009
- Low von Willebrand factor: sometimes a risk factor and sometimes a diseaseHematology-American Society Hematology Education Program, 2009
- Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease☆European Journal of Cardio-Thoracic Surgery, 2008
- Advanced heart failure: feasibility study of long-term continuous axial flow pump supportEuropean Heart Journal, 2005
- Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation—a preliminary study1European Journal of Cardio-Thoracic Surgery, 2004
- Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchangeBlood, 2002
- Function of von Willebrand Factor in Children with Diarrhea-Associated Hemolytic-Uremic Syndrome (D+ HUS)Seminars in Thrombosis and Hemostasis, 2001